Literature DB >> 81285

Hyperreactive (hyaline, opaque, dark) muscle fibers in Duchenne dystrophy. A biopsy study of 16 dystrophy and 205 other neuronmuscular disease cases and controls.

K Boxler, F Jerusalem.   

Abstract

Biopsies of 16 patients with Duchenne dystrophy and 205 consecutive biopsies of other neuromuscular diseases and controls were studied for the presence of hyperreactive (hyaline, dark, opaque) fibers. All biopsies of Duchenne dystrophy showed hyperreactive fibers; the percentage varies between values below 1 up to 19 (median 3.5%). In 11 (69%) of the 16 biopsies the percentage was more than 1. Only in 34 (17%) of the 205 consecutive biopsies were hyperreactive fibers found. In 30 of these 34 biopsies the percentage of hyperreactive fibers was below 1. A positive or negative correlation between the increased level of serum-CPK or the early stage of Duchenne dystrophy and the number of hyperreactive fibers could not be demonstrated. Obviously the hyperreactive fibers are not specific for Duchenne dystrophy. On the other hand a value of 1% supports this diagnosis. Delta lesions were demonstrated in 54% of the hyperreactive fibers.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81285     DOI: 10.1007/BF00313369

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  Stages in fibre breakdown in Duchenne muscular dystrophy. An electron-microscopic study.

Authors:  M J Cullen; J J Fulthorpe
Journal:  J Neurol Sci       Date:  1975-02       Impact factor: 3.181

2.  Histopathological features of muscle in the preclinical stages of muscular dystrophy.

Authors:  C M PEARSON
Journal:  Brain       Date:  1962-03       Impact factor: 13.501

3.  Muscle histology in fetuses at risk for Duchenne muscular dystrophy.

Authors:  J Toop; A E Emery
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

4.  Contracture knots in normal and diseased muscle fibres.

Authors:  H Schmalbruch
Journal:  Brain       Date:  1973-09       Impact factor: 13.501

5.  Histopathological changes in Duchenne muscular dystrophy.

Authors:  C D Bell; P E Conen
Journal:  J Neurol Sci       Date:  1968 Nov-Dec       Impact factor: 3.181

6.  Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber.

Authors:  B Mokri; A G Engel
Journal:  Neurology       Date:  1975-12       Impact factor: 9.910

7.  [Technic of muscle biopsy].

Authors:  F Jerusalem; R Bischhausen
Journal:  Nervenarzt       Date:  1975-01       Impact factor: 1.214

8.  Pre-clinical muscular dystrophy: histopathological changes observed on muscle biopsy.

Authors:  P Hudgson; G W Pearce; J N Walton
Journal:  Brain       Date:  1967-09       Impact factor: 13.501

9.  Structural changes in the early stages of Duchenne muscular dystrophy.

Authors:  W G Bradley; P Hudgson; P F Larson; T A Papapetropoulos; M Jenkison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154

10.  Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies.

Authors:  J B Bodensteiner; A G Engel
Journal:  Neurology       Date:  1978-05       Impact factor: 9.910

  10 in total
  4 in total

1.  Correlative study of the incidence of opaque, necrotic and regenerative fibers in Duchenne dystrophy.

Authors:  M Uchino; S Araki; T Miike
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 2.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Pathophysiology of muscle fiber necrosis induced by bupivacaine hydrochloride (Marcaine).

Authors:  I Nonaka; A Takagi; S Ishiura; H Nakase; H Sugita
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

4.  beta-Lactamase-producing anaerobes.

Authors:  S Reilly; A T Willis
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.